John H Tucker
CIK 1303480 · President and CEO · last filed 2025-10-07
John H Tucker is a President and CEO who has filed 15 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing, for SCPH, was dated Oct 7, 2025. Across all open-market trades the lifetime net is +$65.7K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
15
$65.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| scPharmaceuticals Inc. (SCPH) Delisted | President and CEO | 0 | $5.67 | $0 | $65.7K | 15 | 2025-10-07 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-07 | scPharmaceuticals Inc. (SCPH) Delisted | Mixed | −440,847 | $0 | EDGAR |
| 2025-02-12 | scPharmaceuticals Inc. (SCPH) Delisted | Grant (A) | −200,000 | $0 | EDGAR |
| 2025-01-07 | scPharmaceuticals Inc. (SCPH) Delisted | Tax (F) | −13,360 | -$47.5K | EDGAR |
| 2024-04-02 | scPharmaceuticals Inc. (SCPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-22 | scPharmaceuticals Inc. (SCPH) Delisted | Grant (A) | +113,560 | $0 | EDGAR |
| 2024-01-03 | scPharmaceuticals Inc. (SCPH) Delisted | Tax (F) | −4,942 | -$31.6K | EDGAR |
| 2023-01-23 | scPharmaceuticals Inc. (SCPH) Delisted | Grant (A) | +66,665 | $409.3K | EDGAR |
| 2022-10-11 | scPharmaceuticals Inc. (SCPH) Delisted | Mixed | +31,962 | -$51.2K | EDGAR |
| 2022-02-01 | scPharmaceuticals Inc. (SCPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-06 | scPharmaceuticals Inc. (SCPH) Delisted | Buy (P) | +10,000 | $39.6K | EDGAR |